Vinorelbine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Vinorelbine. Educational only — not medical advice.
Labeled uses
Vinorelbine injection is indicated: In combination with cisplatin for first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) As a single agent for the treatment of patients with metastatic NSCLC
Source: FDA labeling via NIH DailyMed (set dd3dcc9a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.